Microsoft Word - 第29回九州支部大会プログラムHP版.docx

Size: px
Start display at page:

Download "Microsoft Word - 第29回九州支部大会プログラムHP版.docx"

Transcription

1

2

3 1A A-02 1, 2 1, 1, 1, 1, 1, 1, 2, 1, 1 1A-03 1, 2, 3 1 1, 2, 3, 2, 3, 2, 3 1A , 2 1, 1, 1, 2, 2, 1 1A-05, 1A-06 sirna PEG /α- 1, 2 1, 1, 1, 1, 1, 2,

4 1 1A-07 1, 2, 3, 4, DDS 5 1, 1, 1, 2, 3, 4, 5, 1, 2 1A-08 1, 2, 3, DDS 4 1, 1, 2, 1 3, 1, 2, 3, 4, 1, 2 1A-09 1, 2, 3, 4 1, 2, 2, 2, 2, 2, 3, 2, 4 1A-10 Apc Min/+ 1, 2, 3 1,, 1,, 2, 2, 3, 3, 1 1A-11,,, 1A-12,,,,,,, 1A-13,,,

5 1A-14 1, 2, 3, 4, 5, 6 1, 2, 3, 4, 4, 4, 5, 5, 2, 2, 2, 6 1A-15 Aldehyde dehydrogenase 2 1, 2, 3, 4 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 2, 2, 3, 4, 4, 4, 4, 4, 4, 4 1A-16 DEM DPP-4 1, 2, 3, 4 1, 2, 2, 2, 2, 3, 4, 4, 4, 4, 2, 3 1A-17,,,,, 1A-18 Fexofenadine enantiomers OATPs P-gp , A-19 Sulbactam Acinetobacter baumannii PK-PD , , 2

6 1A-20 1, () 2, 3, 4 1, 1, 1, 1, 2, 3, 3, 4, 1 1A-21 1, 2 1, 1, 2, 1 1B-01 p21 1, 2 1, 1, 1, 2, 2, 1 1B-02 SLRP family tsukushi LPS 1, 2 1, 1, 1, 1, 1, 2, 1 1B-03 β 2,,, 1B-04 EP4 1, 2 1, 2, 1, 1, 1, - 2, 1 1B-05 1, 2, 3 1, 1, 1, 2, 3, 1, 1, 1 1B-06 HIV 1, 2, 3 1, 1, 1, 2, 2, 2, 2,

7 1, 1, 1, 3, 1 1B-07 1, 2, 3, 4 1, 2, 1, 1, 1, 3, 4, 4, 1, 2, 2 1B-08 Myosin1E 1, 2 1, 1, 1, 1, 1, 2 1B-09 UNC45 Myosin1E 1, 2 1, 1, 1, 1, 1, 2 1B-10 MEK,,, 1B-11 B MAPKp38 1, 2 1, 2, 1 1B-12 DNA,,,,,,,, 1B-13 Caco-2 Progranulin,,,,,,,,,, 1B-14 1, 2 1, 2, 2, 1, 2, 2, 1

8 1B-15 G-CSF 1, 2 1, 2, 1, 1, 1 1B-16 N 1, 2 1, 1, 1, 1, 2, 1 1B-17 T IL-2,,,,,,,, 1B-18 Mast Cell Histamine 1, 2, 3 1, 2, 1, 1, 1, 2, 3, 2 1B-19,,,,,,,, 1B-20,,,,,, 1C-01 1, 2 1, 1, 1, 2, 1 1C-02 Lewis 1, 2

9 1, 2, 1, 1 1C-03 cis-,,,, 1C-04,,,, 1C-05 α- 1, 2 1, 1, 1, 1, 2, 2, 1 1C-06,, 1C-07,,, 1C-08,, 1C-09 44, A,,, 1C-10 cis- 1, 2 1, 2, 2, 2 1C-11 [5],, 1C-12-1,2-

10 ,, 1C , 2, 3 1, 1, 2, 2, 3, 1 1C-14 DNA,, 1C-15 2 DNA, 1C-16 PH myo- 1, 2, 3 ) 1, 2, 2, 3, 2 1C-17 SN-1 1, 2, 3, 4 1, 2, 3, 4, 4, 3, 1, 3 1C-18 manzamine A 1, 2 1, 2, 1, 2, 1 1C-19 1, 2 1, 2, 1, 2 1C-20 3-,,,

11 1D-01 GA-pyridine,,,,, 1D-02 Schotten-Baumann HPLC,,,,,,, 1D I,,,,,,, 1D-04 1, 2, () 3 1, 1, 2, 3, 2, 3, 2, 1, 1, 1 1D-05 TCDD PenCDF 1, 2, 3, 4 1, 1, 1, 1, 2, 3, 4, 3, 1 1D-06 Δ 9 -THC : 2 (ERβ) 1, 2 1, 1, 1, 1, 1, 1, 2, 1 1D-07 64M5

12 1, 2 1, 1, 2, 1 1D-08 MPP + SIA//,,,,, 1D-09 dihydropyrazine,, 1D-10 dihydropyrazine,, 1D-11 GA-pyridine 1, 2, 3 1, 1, 2, 3, 1 1D-12 MutT 8-oxo-dGTP, 1D-13,,,,, 1D-14,,, 1D-15 -β- 1, 2, DDS 3 1, 1, 1, 2, 3, 1 1D-16 NSAIDs

13 1, 2 1, 1, 1, 1, 2, 1, 2, 1 1D-17 GT1-7,,,,, 1D-18 (FnHmOH) 1, 2 1, 1, 1, 1, 2, 1 1D-19 (F8HmOH) DPPC,,,, 1D-20 n-,,,, 1A-22 Epigallocatechin-3-gallate (EGCg) 1, 2 1, 1, 1, 2, 1, 1, 1, 2, 1 1A-23,, 1A-24 CDDP 1, 2, 3 1, 2, 1, 2, 1, 1, 3, 2 1A-25 sirna

14 1, 2 1, 2, 1, 2, 1, 2 1A-26 1, 2 1, 2, 1, 2, 1, 2 1A-27,,,,, 1A-28 PEG /α- (G4) sirna,,,, 1A-29 PEG /α- sirna,,,, 1A-30,,, 1A-31 TTR 1, 2 1, 1, 2, 1, 1, 2, 2, 2, 1, 1, 2 1B-21 DSS NO TLR4-NFκB, 2 1, 1,2, 1

15 1B-22, 2, 2,, 1B , 2 1, 1, 1, 2, 1 1B-24 P450 3A4 (CYP3A4) UDP- (UGT)1A UGT UGT 1, 2, 3, 4, 5 1, 1, 1, 2, 3, 4, Peter I. Mackenzie 5, 1 1B-25 3T3-L1 liver PPAR γ-dependent gene 1 shrna 1, 2 1, 1, 2, 1 1B-26 HIV-1 1, 2 1, 1, 1, 1, 1, 2, 1 1B-27 HIV-1 Gag p2 1, 2 1, 1, 1, 1, 1, 1, 1, 2, 1 1B-28 CCR5 1, 2, 3 1, 1, 1, 2, 2, 1, 1, 1, 3, 1 1B-29 1, 2, R&D 3 1, 2, 3, 1, 3, 2, 1

16 1B-30 1, 2, R&D 3 1, 1, 1, 2, 2, 3, 3, 2 1C-21 Hyrtios reticulatus E1,,,, 1C-22 6-epi-Notoamide T,,, 1C-23 ( 8 ) Amgad Ibrahim Mansour Khedr, 1C-24 1, 2 1, 2, 2, 1, 1 1C-25,, 1C-26 1, 2 1, 1, 2, 2, 1 1C-27,,, 1C-28 1, 2 1, 2, 1, 1, 1

17 1C-29 Induction of apoptosis in human leukemia cell lines by coumarines from Mammea siamensis 1, 2 Nguyen Huu Tung 1, 1, 1, 1, 1, Sorasak Lhieochaiphant 2 1 1C-30 M1 1, 2 1, 1, Wariya Sanrattana 2, 1, 1, 1 1D-21,, 1D-22,, 1D-23,,,, 1D-24 Hydroxylated S- PCB in vitro,,,,, 1D-25 1, 2 1, 1, 2, 2, 1 1D-26 MDMA 1, 2, 3

18 1, 2, 2, 2, 2, 3 1D-27 1, 2, 3 1, 1, 1, 2, 3, 3, 1 1D-28,,,,, 1D-29 HPLC 1, 2 1, 1, 2, 1, 1, 1, 1, 1 1D-30 HPLC,,,,,,, 2A-01,,,,, 2A-02 1, 2 1, 1, 1, 2, 1, 1 2A-03 DNA mir-328,,, 2A-04 PCFT

19 ,,, 2A-05 Docetaxel PPK/PD 1, 2, 3 1, 2, 1, 1, 3, 3, 1 2A-06 1, 2 1, 2, 1, 1, 2, 1 2A-07 P-gp CYP3A A-08,,, 2A-09 1, 2, 3 1, 1, 1, 2, 2, 3, 2 2A-10 1, 2, 3 1, 1, 1, 1, 2, 2, 2, 2, 3, 2 2A-11 1, 2, 3, 4, 5 1, 1, 1, 1, 1, 1, 1, 2, 2, 2, 3, 4, 2, 5 2A-12

20 1, 2, 3, 4 1, 1, 1, 2, 2, 1, 1, 2, 2, 2, 3, 4, 4, 4, 4, 4, 4, 4 2A-13 Cytochrome P450 2C19 1, 2, 3, 4, 5 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 2, 3, 4, 2, 5 2A-14 To Study Efficacy and Safety of Tab. Losartan 50 mg therapy in De Novo patients with essential hypertension School of Health and Allied Sciences, Pokhara University, Lekhnath, Nepal 1, 2 Gulam Muhammad Khan 1, Biraj Khanal 1, Birendra Dhakal 1, Dipak Kumar Sharma 1, Nabin Thapa Magar 1, Santusta Adhikari 1, Til Bahaduar Thapa Magar 1, 2 2A-15 Bleomycin hydrolase 1, 2 1, 1, 2, 1, 1 2A-16 Activating Transcription Factor-4 (ATF4) shrna 1, 2 1, 1, 2, 1, 1 2B-01 5-HT1A

21 ,,,,,, 2B-02 1, 2 1, 1, 1, 1, 1, 2, 1 2B-03 Communication Box 1, 2 1, 1, 1, 1, 1, 2, 1 2B-04 GABAB D2,,,,,, 2B-05,,,,, 2B-06,,, 2B-07 Band3,,,,, 2B-08 HuCHRAC 1, 2, 3 1, 1, 1, 1, 2, 2, 2, 2, 3, 3, 1, 1

22 2B-09 GRK5,,,, 2B-10 IL-33 E2,,,, 2B-11 Ca 2+ embryospacing 1, 2, 3, 4 1, 1, 2, 1, 1, 1, 3, 3, 4, 1 2B-12 ( 1 ),,,,, 2B-13, Phosphoglycerate mutase 4 (PGAM4) Single Nucleotide Polymorphism (SNP) 1, () 2, 3 1, 1, 2, 1, 1, 1, 1, 1, 1, 3, 3 2B-14,,,,,,, 2B-15,,,,,,, 2B-16 DTNB,,,,,,, 2B-17 DSS NO

23 , 2 1, 2, 1, 1, 2, 1 2C-01 Lewis DIOP 1, 2 1, 2, 1, 1 2C-02 N-,, 2C-03 Lewis, 1,3-1, 2 1, 2, 1, 1 2C , 2 1, 2, 1, 1 2C-05 C-O,,, 2C-06,,,,, 2C-07 1, 2 1, 1, 2, 2 2C-08

24 ,,, 2C-09 Rh(II) C-H,,, 2C-10,,, 2C-11 1, 2 1, 2, 2, 1 2C-12 β- 1, 2 1, 2, 1, 2, 1 2C-13,, 2C-14 C-,, 2C-15 3 DNA,, 2C-16 NMR 1, 2 1, 1, 2, 2, 2, 1

25 2D-01 HPLC-Ru(bpy)3 2+ 1, 2, 3 1, 2, 2, 2, 3 2D-02,,,,, 2D-03,,,, 2D-04,,,,,,, 2A-17 1, 2 1, 1, 1, 2, 1, 1 2A-18 The strengthening effect of BRAND's Essence of Chicken on the entrainment function of mammalian circadian clock Adila Dilxat,,, 2A-19 Clock,,,, 2A , 2, 2, 2, 2, 2, 1,2 2A-21 -

26 1, 2, 3, 4, DDS 5 1, 1, 1, 2, 3, 1, 2, 3, 4, 5, 1, 2 2A-22 (HK-2 cell),,,,,, 2A-23 in vivo 1, 2 1,,, 2, 1 2A-24 AKI L-FABP PN 1, 2 1, 2, 1, 1, 1 2A-25 1, 2, 3, 4, DDS 5 1, 1, 1, 1, 2, 1, 2, 3, 4, 5, 1, 2 2A-26 -CHOP 1, 2, 3, 4, 5 1, 2, 3, 2, 2, 2, 4, 2, 2, 5 2A-27 1, 2, 3, 4 1, 2, 2, 3, 2, 3, 2, 4 2A-28 1, 2, 3, 4

27 1, 2, 2, 2, 3, 3, 1, 1, 4 2A-29 2,, 2A-30 1, BODOR Laboratories 2 1, 1, Nicholas Bodor 2, 1 2C-17 ADAM 1, 2, 3 1, 2, 3, 2 2C-18 1, 2, 3 1, 2, 2, 2, 3, 2 2C-19 Antioxidant and tyrosinase inhibitory compounds from Diplomorpha plants () 1 2 Devkota Hari Prasad 1, 2, 1 2C-20 Phenolic compounds from Pterocarpus marsupium 1, Pokhara University, Nepal 2 Joshi Khem Raj 1, 2, Devkota Hari Prasad 1, 1 2C-21 Allium Sulfides (20) Garlic () 2C-22 (4)

28 1, 2, 3, 4 1, 1, 1, 1, 1, 2, 2, 3, 3, 4, 4, 1 2C-23 Indium(III) Chloride (1) 1, 2, 3 1, 1, 1, 2, 2, 3, 3, 1 2C-24 (3) 1, 2, 3 1, 1, 1, 1, 1, 2, 2, 3, 3, 1

Microsoft Word - web.docx

Microsoft Word - web.docx 12 10 E 16:30 17:30 : ( ) " " ( ) 12 10 15:50 16:20 A 1 ( ) ( ) B ( ) ( ) D ( ) ( 12 11 B 10:00 12:00 " " ( ) ( ) 2 (10 ) A 1 ( ) 8:30 12:40 8:30 9:20 1 ( ) 1A-01 Cannabidiol-2',6'-dimethyl ether ( 1,

More information

日本医科大学医学会雑誌第8巻第1号

日本医科大学医学会雑誌第8巻第1号 Xenopus laevis in situ μ μ Xenopus laevis Xenopus laevis Xenopus laevis UGT1A1 UGT1A1 IL28B KRAS UGT1A1 UGT1A128 UGT UGT1A1 UGT1A128 UGT1A1 286 UGT1A1 UGT1A1 28 6 UGT UGT UGT1A128 UGT IL28B UGT1A1

More information

第86回日本感染症学会総会学術集会後抄録(I)

第86回日本感染症学会総会学術集会後抄録(I) κ κ κ κ κ κ μ μ β β β γ α α β β γ α β α α α γ α β β γ μ β β μ μ α ββ β β β β β β β β β β β β β β β β β β γ β μ μ μ μμ μ μ μ μ β β μ μ μ μ μ μ μ μ μ μ μ μ μ μ β

More information

nsg02-13/ky045059301600033210

nsg02-13/ky045059301600033210 φ φ φ φ κ κ α α μ μ α α μ χ et al Neurosci. Res. Trpv J Physiol μ μ α α α β in vivo β β β β β β β β in vitro β γ μ δ μδ δ δ α θ α θ α In Biomechanics at Micro- and Nanoscale Levels, Volume I W W v W

More information

1 911 9001030 9:00 A B C D E F G H I J K L M 1A0900 1B0900 1C0900 1D0900 1E0900 1F0900 1G0900 1H0900 1I0900 1J0900 1K0900 1L0900 1M0900 9:15 1A0915 1B0915 1C0915 1D0915 1E0915 1F0915 1G0915 1H0915 1I0915

More information

O1-1 O1-2 O1-3 O1-4 O1-5 O1-6

O1-1 O1-2 O1-3 O1-4 O1-5 O1-6 O1-1 O1-2 O1-3 O1-4 O1-5 O1-6 O1-7 O1-8 O1-9 O1-10 O1-11 O1-12 O1-13 O1-14 O1-15 O1-16 O1-17 O1-18 O1-19 O1-20 O1-21 O1-22 O1-23 O1-24 O1-25 O1-26 O1-27 O1-28 O1-29 O1-30 O1-31 O1-32 O1-33 O1-34 O1-35

More information

9 : 00 11 : 00 12 : 00 12 : 10 12 : 50 13 : 30 14 : 40 16 : 00 17 : 00

9 : 00 11 : 00 12 : 00 12 : 10 12 : 50 13 : 30 14 : 40 16 : 00 17 : 00 9 : 00 11 : 00 12 : 00 12 : 10 12 : 50 13 : 30 14 : 40 16 : 00 17 : 00 ポスターについて 1. ポスター 貼 付 用 の 展 示 ボードは 縦 180 横 90cm の 大 きさです 2. 演 題 名 発 表 者 名 所 属 を 明 記 したもの(20 70cm) をご 用 意 ください 実 際 使 用 できるスペースは 155

More information

(2009) 1... / 1 ( ) / 1 ( ) / 1 ( ), 2 ( )

(2009) 1... / 1 ( ) / 1 ( ) / 1 ( ), 2 ( ) 212009................................................ 2............................................ 115 (2009) 1... / 1 ( )........................................... 4 2... / 1 ( )......................................

More information

第14〜15回 T細胞を介する免疫系.pptx

第14〜15回 T細胞を介する免疫系.pptx MBL CD8 CD4 8.1 8.2 5.20 8.3 8.4 8.5 8.6 8.7 8.8 8.9 8.10 8.18 B7 CD28 CD28 B7 CD28 8.13 2.22 NK Toll(TLR) LBP! LPS dsrna ssrna TLR1/2/6! TLR4 TLR5 TLR3 TLR7/9 CD14! JNK/p38! MyD88! IRAK! TRAF! NFκB! TNF-α

More information

nsg04-28/ky208684356100043077

nsg04-28/ky208684356100043077 δ!!! μ μ μ γ UBE3A Ube3a Ube3a δ !!!! α α α α α α α α α α μ μ α β α β β !!!!!!!! μ! Suncus murinus μ Ω! π μ Ω in vivo! μ μ μ!!! ! in situ! in vivo δ δ !!!!!!!!!! ! in vivo Orexin-Arch Orexin-Arch !!

More information

研修コーナー

研修コーナー l l l l l l l l l l l α α β l µ l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l

More information

日歯雑誌(H28・8月号)別刷り/ポスターセッション とびら

日歯雑誌(H28・8月号)別刷り/ポスターセッション とびら α P. gingivalis P. gingivalis αsmatgf- VEGF-A α in vitro μ Porphyromonas gingivalis in vitro Porphyromonas gingivalis β β β JBiolChem. μ μ μ β Porphyromonas gingivalis in vitro μ α β α

More information

NL10

NL10 Information September, 2006 1 2 Japanese Association for Molecular Target Therapy of Cancer News Letter No.10 September, 2006 3 2006 4 Japanese Association for Molecular Target Therapy of Cancer News Letter

More information

Ethanol Preconditioning (EPC) enos(cgrp) 1 Korthuis RJ Medical Pharmacology and Physiology University of Mi

Ethanol Preconditioning (EPC) enos(cgrp) 1 Korthuis RJ Medical Pharmacology and Physiology University of Mi (9:40 9:50) (9:50 10:30) O-01 1 2 2 2 2 2 2 2 2 2 3 3 4 4 1 2 3 4 O-02 15-deoxy-Δ 12,14 -PGJ 2 Heme oxygenase-1(ho-1) 1 2 3 3 3 3 3 3 1 1 5 4 3 2 3 4 5 O-03 C hepcidin 1 1 1 1 1 1 1 1 1 2 2 2 2 1 2 O-04

More information

NL09

NL09 Information September, 2005 1 2 Japanese Association for Molecular Target Therapy of Cancer News Letter No.9 September, 2005 3 2005 4 Japanese Association for Molecular Target Therapy of Cancer News Letter

More information

00hyoshi

00hyoshi Network and Information 2012 SENSHU UNIVERSITY School of Network and Information 2 3 4 6 8 10 12 14 16 18 20 22 24 26 27 28 1 2 3 4 Business Human being Technology Information Communication Technology

More information

124

124 [ ] [ ] 18 123 124 ( ) 125 126 127 128 5,683,062 2,306,419 18.2 14.0 12 5389 87 13 257 88 12 22 27 56.7 41.6 1 1.7 15 129 55 38.8 13.3 15 2004 15 1 3 84.8 29.3 1 23.9 38.0 10 10 35 35 15 5 56.5.31 55.4.1

More information

10 : 3010 : 54 1F Annex 1! 1 15:3015 : 58 1F Annex 1

10 : 3010 : 54 1F Annex 1! 1 15:3015 : 58 1F Annex 1 4 16 1 10:0010 : 24 1F Annex 1! 2 15:0015 : 24 1F Annex 1!! 10 : 3010 : 54 1F Annex 1! 1 15:3015 : 58 1F Annex 1 ! 2 10:0010 : 28 1F Annex 1 3 15:0015 : 28 1F Annex 1 4 10:3010 : 58 1F Annex 1 1 15:3015

More information

EL-G37

EL-G37 EL-G37 A A A A A A A A A A A A A A GT F543210A CE CA 4 00. 00 23.80 2 015.6250 77.14286 96. 91. 102. 25. 9. 1 700. 2 720. 2.5 7. 20. 25. 220. 400. 4 096. 4.685 0.084 M 125. M 28. M 85.

More information

ミニレビュー

ミニレビュー Molecular mechanisms of the suppression of inflammation by thermal stress Ryosuke Takii Department of Biochemistry and Molecular Biology, Yamaguchi University Graduate School of Medicine, Ube 755-8505,

More information

さくらの個別指導 ( さくら教育研究所 ) 1 φ = φ 1 : φ [ ] a [ ] 1 a : b a b b(a + b) b a 2 a 2 = b(a + b). b 2 ( a b ) 2 = a b a/b X 2 X 1 = 0 a/b > 0 2 a

さくらの個別指導 ( さくら教育研究所 ) 1 φ = φ 1 : φ [ ] a [ ] 1 a : b a b b(a + b) b a 2 a 2 = b(a + b). b 2 ( a b ) 2 = a b a/b X 2 X 1 = 0 a/b > 0 2 a φ + 5 2 φ : φ [ ] a [ ] a : b a b b(a + b) b a 2 a 2 b(a + b). b 2 ( a b ) 2 a b + a/b X 2 X 0 a/b > 0 2 a b + 5 2 φ φ : 2 5 5 [ ] [ ] x x x : x : x x : x x : x x 2 x 2 x 0 x ± 5 2 x x φ : φ 2 : φ ( )

More information

zsj2017 (Toyama) program.pdf

zsj2017 (Toyama) program.pdf 88 th Annual Meeting of the Zoological Society of Japan Abstracts 88 th Annual Meeting of the Zoological Society of Japan Abstracts 88 th Annual Meeting of the Zoological Society of Japan Abstracts 88

More information

88 th Annual Meeting of the Zoological Society of Japan Abstracts 88 th Annual Meeting of the Zoological Society of Japan Abstracts 88 th Annual Meeting of the Zoological Society of Japan Abstracts 88

More information

_170825_<52D5><7269><5B66><4F1A>_<6821><4E86><5F8C><4FEE><6B63>_<518A><5B50><4F53><FF08><5168><9801><FF09>.pdf

_170825_<52D5><7269><5B66><4F1A>_<6821><4E86><5F8C><4FEE><6B63>_<518A><5B50><4F53><FF08><5168><9801><FF09>.pdf 88 th Annual Meeting of the Zoological Society of Japan Abstracts 88 th Annual Meeting of the Zoological Society of Japan Abstracts 88 th Annual Meeting of the Zoological Society of Japan Abstracts 88

More information

1 3 1.1.......................... 3 1............................... 3 1.3....................... 5 1.4.......................... 6 1.5........................ 7 8.1......................... 8..............................

More information

Title 骨量規定転写因子シュニュリ3の新規標的遺伝子同定と機能解析 Author(s) 石堂, 康弘 Citation Issue Date 2014-06-27 URL http://hdl.handle.net/10232/24125 http://ir.kagoshima-u.ac.jp adult (Schnurri, Shn)3/Hivep3 Runx2 Shn/Hivep Shn3

More information

gtf Wnt5a-Ror2 IL-8 in vitro Ozony Tron P. gingivalis SOD ELISA Location of main occluding areas and masticatory ability in patients with reduced occlusal support 12-Methacryloyloxydodecylpyridinium bromide

More information

喘息について\(公健協会宛02-5作成\)

喘息について\(公健協会宛02-5作成\) Q & A Q & A 1.? 20 2. 1) 2) 3) 4) 5) 6) 7) 1) 2) 3) 4) 5) 6) 7) 8) 9) 3. NHK ( ) 4 10 1 200mg ( ) ( 1 ) 4. ( ) ( ) 5. ( ) ( ) 6. β 2 ( ) 7. ( ) 1 8. 1. 2. 3. 4. 5. 6. 7. 8. 9. 2 5 7 1. 1 10 1) 2) 3) 30

More information

The Bulletin of the Institute of Human Sciences, Toyo University, No. 7 The Semantic Role and Function of GA and WO as object markers in Japanese WANG Yaxin The purpose of this paper is to analyze the

More information

平塚信用金庫の現況 2015

平塚信用金庫の現況 2015 2015 1 2 3 1 2 3 4 5 6 7 1 2 3 4 5 8 9 @ A B C D E F G H I J K HK L M N O P Q R T R T S T U V W 1 2 3 4 5 6 E F C J I O M N K L H 8 7 G D 0 A 6 9 5

More information

Inhibitory effect of 5β-pregnane-3α Titletranscriptional activity and enzyme UDP-glucuronosyltransferase (UGT1A1 Author(s) 森岡 ( 太田 ), 依子 Citation Issue Date 2011-09-14 URL http://hdl.handle.net/10422/1397

More information

(Quality of Life; QL) QL (Nerve Growth Factor; NGF) NGF PC12 6- (6-HITC) NGF NGF NGF PTP1B 6-HITC PTP1B NGF PTP1B 6-HITC PTP1B 6-HITC NGF 6-HITC 6-HITC in vivo 464-8601 Tel: 052-789-4126 20-Hydroxyecdysone

More information

2

2 2 3 4 5 6 7 8 9 1 2 3 4 5 10 11 12 1 2 1 2 1 2 13 14 3 17 15 1 2 3 D Usefulness of Tc-99m MIBI SPECT in predicting multidrug resistance gene expression level in non-small cell lung cancer a preliminary

More information

EP7000取扱説明書

EP7000取扱説明書 EP7000 S0109-3012 3 47 811 1213 1419 2021 53 54 5560 61 6263 66 2223 2427 2830 3133 3436 3740 4142 4344 45 46 4750 5152 2 4 5 6 7 1 3 4 5 6 7 8 9 15 16 17 18 13 EP7000 2 10 11 12 13 14 19 20 21 22 23 24

More information

50mg 75mg (1) H 3 C O OH HO H O O H OH SO H 3 Na H H N H 2 N NH OH H N O O H H O OH H 3 C H O O N H H H HO H NH CH 3 HN HO H OH O H OH H NH

50mg 75mg (1) H 3 C O OH HO H O O H OH SO H 3 Na H H N H 2 N NH OH H N O O H H O OH H 3 C H O O N H H H HO H NH CH 3 HN HO H OH O H OH H NH 3240 14 8 8 50mg 75mg 13 6 25 1-(1) H 3 C O OH HO H O O H OH SO H 3 Na H H N H 2 N NH OH H N O O H H O OH H 3 C H O O N H H H HO H NH CH 3 HN HO H OH O H OH H NH O N O C 56 H 70 N 9 NaO 23 S 1292.26 5-[(1S,2S)-2-

More information

University of Tsukuba2014

University of Tsukuba2014 University of Tsukuba S c h o o l o f H e a l t h & P h y s i c a l E d u c a t i o n University of Tsukuba 2014 http://www.taiiku.tsukuba.ac.jp University of Tsukuba2014 School of Health & Physical Education,

More information

<4D F736F F D20342D D834F DA8E9F5F8AAE97B95F>

<4D F736F F D20342D D834F DA8E9F5F8AAE97B95F> H. pylori S1-1 Hp S1-2 H. pylori S1-3 S1-4 75 Helicobacter pylori () S1-5 S1-6 Helicobacter pylori S1-7 H. pylori () S1-8 Helicobacter pylori () : H. pylori S2-1 H. pylori Ferric uptake regulator(fur)

More information

再生医科学研究所年報 Annual Report of the Institute for Frontier Medical Sciences Kyoto University Institute for Frontier Medical Sciences 1 2 3 4 5 6 Institute for Frontier Medical Sciences 1 Annual Report 2011

More information

.r.[...X.j...[.X5..-.{..4C

.r.[...X.j...[.X5..-.{..4C Hiroshima University Graduate School of Biomedical Sciences Streptococcus mutanss. sobrinus S. mutanss. mutanss. sobrinuss. sanguinis S. salivariuss. mitis in vivo S. mutanss. sobrinus S.mutans

More information

15K00827 研究成果報告書

15K00827 研究成果報告書 (TG) TG sterol regulatory element- binding protein (SREBP)-1c (Diabetes 53:560-569, 2004) SREBP-1c (1) SREBP-1c SREBP-1c liver X receptor (LXR)LXR O-Glc NAc (O-linked -N-acetyl glucosamine) (J Biol Chem

More information

untitled

untitled ... 4...5...6...7...10...11... 12...12...12...13...14...15...15...16...16...17...17...18...18...19...19...19 Hill...20...20...21...21...22...23...24...25... 34...34...35...38-2 - ...41...49...51...51...51...52...53...56...56...57...60...60-3

More information

/ 3 1 / 3 / 3 1 /

/ 3 1 / 3 / 3 1 / 8-18-29 3 291415 297 1-11-4 3/31/ 3/31/ 29 8 22 29 1 17 24 8-1 29 [1] PCB [2] HCB [3] [4] [5] DDT [6-1] p,p'-ddt [6-2] p,p'-dde pg/l ( ) nd 2,4 (46/47) 2.9 18 (47/47) 84 12 pg/g-dry ( ) nd 61, (61/62)

More information

11 16 ( ) S S , S S S1-P1 Dual-targeting Photoimmunotherapy 58 S1-P2 diffuse

11 16 ( ) S S , S S S1-P1 Dual-targeting Photoimmunotherapy 58 S1-P2 diffuse 11 16 ( ) 1 11 16 ( ) 2 11 17 ( ) 1 11 17 ( ) 2 41 11 16 ( ) 11 2 17 ( ) 11 17 ( ) 1 11 16 43 1 46 95 1 54 2 62 2 67 3 75 1 106 2 109 1 83 2 85 1 91 2 93 129 2 11 17 2 47 49 100 3 70 4 78 1 59 3 112 4

More information

2 1 1 α = a + bi(a, b R) α (conjugate) α = a bi α (absolute value) α = a 2 + b 2 α (norm) N(α) = a 2 + b 2 = αα = α 2 α (spure) (trace) 1 1. a R aα =

2 1 1 α = a + bi(a, b R) α (conjugate) α = a bi α (absolute value) α = a 2 + b 2 α (norm) N(α) = a 2 + b 2 = αα = α 2 α (spure) (trace) 1 1. a R aα = 1 1 α = a + bi(a, b R) α (conjugate) α = a bi α (absolute value) α = a + b α (norm) N(α) = a + b = αα = α α (spure) (trace) 1 1. a R aα = aα. α = α 3. α + β = α + β 4. αβ = αβ 5. β 0 6. α = α ( ) α = α

More information

indd

indd Molecular Targeted Therapy for Lung Cancer from a Pharmaceutical Point of Viewe Naho SASAKI epidermal growth factor receptor tyrosine kinase inhibitor :EGFR-TKI vascular endothelial growth factor:vegf

More information

University of Tsukuba 2015 School of Health & Physical Education

University of Tsukuba 2015 School of Health & Physical Education University of Tsukuba University of Tsukuba 2015 体育専門学群 School of Health & Physical Education http://www.taiiku.tsukuba.ac.jp University of Tsukuba 2015 School of Health & Physical Education School of

More information

Microsoft Word - 表紙資料2-4

Microsoft Word - 表紙資料2-4 (1) / 130 g 25 g 520% 170 g 30 g 560% 70 mg 600 mg 11.6% 0 10.5 mg 0% (1) (2) / 50100 g 25 g 200400% 50100 g 30 g 167333% 5001000 mg 600 mg 83167% 1020 mg 10.5 mg 95190% (2) / (1) 45.6 g 30 g 152% (2)

More information

研修コーナー

研修コーナー l l l l l l l Department of Obstetrics and Gynecology, Fukui Medical University, Fukui l l l l l l µ l β β l α l µ µ l l l l Department of Obstetrics and Gynecology, Gifu University School of Medicine,

More information

第124回日本医学会シンポジウム

第124回日本医学会シンポジウム III γ γ γ α γ Molecular Mechanism of Insulin Resistance by Adipocytes TAKASHI KADOWAKI Department of Metabolic Diseases, Graduate School of Medicine, University of Tokyo Key words γ 110 124 TNFα FFA 1,2

More information

兵庫県立大学学報vol.17

兵庫県立大学学報vol.17 THE UNIVERSITY OF HYOGO NEWS 2014 VOL.17 THE UNIVERSITY OF HYOGO NEWS 2014 VOL.17 THE UNIVERSITY OF HYOGO NEWS 2014 VOL.17 THE UNIVERSITY OF HYOGO NEWS 2014 VOL.17 School of Human Science and Environment

More information

計算機生命科学の基礎II_

計算機生命科学の基礎II_ Ⅱ 1.4 atsushi_doi@cell-innovator.com 812-8582 3-1-1 8 806 http://www.cell-innovator.com BioGPS Connectivity Map The Cancer Genome Atlas (TCGA); cbioportal GO DAVID, GSEA WCGNA BioGPS http://biogps.org/

More information